Posts Tagged ‘Nader Fathi’
Enlil Announces Seven Strategic Partnerships
Enlil Announces Seven Strategic Partnerships to Accelerate MedTech Innovation and Customer FDA Clearance Success Campbell, Calif. – July 31, 2025 — Enlil, Inc., a Shifamed Portfolio Company and leader in enabling MedTech product innovation, today announced seven new strategic partnerships formed to date in 2025. These agreements, spanning referral, reseller, deployment, and regulatory consulting collaborations,…
Read MoreEnlil CEO Nader Fathi on Solving MedTech’s Biggest Innovation Challenge
In an exclusive conversation with Joe Mullings, Nader Fathi, CEO of Enlil, shares how the company is transforming medical device innovation. In this informative interview, Enlil CEO Nader Fathi joins Joe Mullings of The Mullings Group and the Dragonfly Media team at 160 Studios to share the story behind Enlil’s founding and mission. He explains how Enlil is…
Read MoreEnlil’s Purpose Built Development Traceability Platform Gains Momentum Across the Global MedTech Ecosystem
The all-in-one, cloud-native solution integrates AI-powered intelligence to transform how OEMs and contract manufacturers manage development, ensure compliance, and accelerate time-to-market. Campbell, CA – April 28, 2025 – Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated products with its comprehensive development traceability platform, today announced growing momentum across the global MedTech innovation ecosystem.…
Read MorePoised for Growth, Enlil, a Shifamed Portfolio Company, Appoints Nader Fathi as Chief Executive Officer
New Leader Set to Propel Global Expansion and Technology Innovation Campbell, CA – March 4, 2025 – Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated product companies with its comprehensive development traceability platform, today announced the appointment of Nader Fathi as Chief Executive Officer. Nader brings over 30 years of unparalleled experience driving…
Read More